Related Experiment Video
Updated: Jun 16, 2025

09:50
A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
Published on: November 2, 2019
8.1K
Synergistic Effect of Stromal Vascular Fraction and Lymph Node Transfer in a Rabbit Hindlimb Model
Jaemin Lee1, Jihyun Kim1, Jeong-Hyun Cheon2
1Department of Plastic and Reconstructive Surgery, Korea University Anam Hospital, 73 Goryeodae-Ro, Seongbuk-Gu, Seoul, 02841, Republic of Korea.
Tissue Engineering and Regenerative Medicine
|June 14, 2025
Summary
Combining stromal vascular fraction (SVF) with vascularized lymph node transfer (VLNT) in a single stage enhances lymph node viability and structural integrity, offering a promising therapy for lymphedema.
Area of Science:
- Regenerative Medicine
- Vascular Biology
- Stem Cell Therapy
Background:
- Adipose-derived stem cells (ADSCs) promote lymphangiogenesis, but their integration with vascularized lymph node transfer (VLNT) is underexplored.
- Stromal vascular fraction (SVF) offers an intraoperative alternative to ADSCs, enabling single-stage VLNT procedures.
- This study investigates the synergistic effects of combining VLNT with SVF therapy.
Purpose of the Study:
- To evaluate the impact of combined VLNT and SVF therapy on lymphedema in a rabbit hindlimb model.
- To assess the enhancement of lymph node viability and structural integrity post-treatment.
- To determine the role of SVF in promoting lymphangiogenesis within the VLNT context.
Main Methods:
- New Zealand white rabbits were assigned to control, VLNT only, SVF only, or combined VLNT plus SVF groups.
- VLNT involved transferring a pedicled lymph node flap; SVF was injected into perinodal tissue.
- Postoperative assessments included edema measurement, ICG lymphography, histology, and VEGF-C/LYVE-1 expression analysis.
Main Results:
- Combined VLNT plus SVF significantly reduced hindlimb edema by week 4 compared to controls.
- Histology revealed superior structural integrity and reduced fibroadipose tissue in the combined treatment group.
- Elevated VEGF-C and LYVE-1 expression were observed in SVF-treated and combined groups, respectively.
Conclusions:
- SVF effectively integrates with VLNT in a single-stage procedure, improving vascularized lymph node viability and structure.
- This combined approach shows potential as a therapeutic strategy for advanced lymphedema.
- Further clinical trials are warranted to explore the efficacy of combined VLNT and SVF therapy.

